HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Lipid formulations of amphotericin].

Abstract
Amphotericin B deoxycholate use has increased during the past years in parallel with the increase in the number of immunosuppressed patients suffering invasive fungal infections. This drug is associated with a high rate of side effects, especially renal toxicity. Lipid formulations (liposomal, lipid complex, colloidal suspension and the Indian liposomal formulation) have been developed, which share the same antifungal spectrum but differ in efficacy and toxicity. A review of amphotericin lipid formulations is presented, focusing on differences in efficacy and, especially renal toxicity. The main problem for use of these formulations in Latin America is their highcost.
AuthorsMartha C Botero, Marcela Puentes-Herrera, Jorge A Cortés
JournalRevista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia (Rev Chilena Infectol) Vol. 31 Issue 5 Pg. 518-27 (Oct 2014) ISSN: 0716-1018 [Print] Chile
Vernacular TitleFormas lipídicas de anfotericina.
PMID25491449 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Antifungal Agents
  • Colloids
  • Excipients
  • Lipids
  • Liposomes
  • Amphotericin B
Topics
  • Amphotericin B (adverse effects, chemistry)
  • Antifungal Agents (adverse effects, chemistry)
  • Colloids
  • Excipients
  • Humans
  • Leishmaniasis (drug therapy)
  • Lipids (chemistry)
  • Liposomes
  • Mycoses (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: